Context Capital Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Context Capital Management’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-27,408	Closed	-$21K	–	607
2022 Q3	$21K	Sell	27,408 -10,000	-27%	-$6.35K	﹤0.01%	417
2022 Q2	$3K	Hold	37,408	–	–	﹤0.01%	596
2022 Q1	$9K	Buy	+37,408	New	+$16.3K	﹤0.01%	656

Context Capital Management's FLACW Position: Q4 2022 in Review

Context Capital Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 27,408 shares — an estimated $21K sold.

Context Capital Management first reported a position in FLACW in Q1 2022 and held it in 3 quarters. The position peaked at $21K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Context Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Context Capital Management sold 27,408 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $21K.
Context Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2022 and held it in 3 quarters.
Context Capital Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $21K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Context Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.